日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE

Durvalumab联合每周一次的卡铂/紫杉醇作为一线治疗方案,用于不适合接受顺铂类化疗的复发性和/或转移性头颈部鳞状细胞癌(HNSCC)患者:多中心前瞻性研究FRAIL-IMMUNE的结果

Fayette, J; Cropet, C; Toullec, C; Burgy, M; Bruyas, A; Sire, C; Lagrange, A; Clatot, F; Vinches, M; Iacob, M; Martin, L; Kaminsky, M-C; Vansteene, D; Salas, S; Champagnac, A; Saintigny, P; Gautier, J; Pérol, D; Bourhis, J

Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC

神经纤维瘤病1型(NF1)相关胃肠道间质瘤(GIST)的临床描述及预后评分的建立:一项来自NETSARC的回顾性研究

Cuvelier, C; Brahmi, M; Sobhani, I; Verret, B; Grancher, A; Penel, N; Toulmonde, M; Lahlou, W; Dupuis, H; Calavas, L; Muller, M; Watson, S; Bruyat, D; Poumeaud, F; Chaigneau, L; Manfredi, S; Lecomte, T; Bertucci, F; Ghiringhelli, F; Pracht, M; Mourthadhoi, F; Monceau-Baroux, L; Helyon, M; Kurtz, J-E; Roquin, G; Regenet, N; Vinches, M; Tougeron, D; Wolkenstein, P; Blay, J Y; Bouche, O; Hautefeuille, V

Evaluation of physical rehabilitation in patients receiving curative treatment for head and neck cancer: The NUTRIMOUV randomized phase II trial

评估接受根治性治疗的头颈癌患者的物理康复效果:NUTRIMOUV 随机 II 期试验

Vinches, Marie; Janiszewski, Chloé; Thezenas, Simon; Delample, Delphine; Boisselier, Pierre; Jacquot, Stéphane; Senesse, Pierre; Faravel, Kerstin

Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report

临床药学举措助力达拉非尼/曲美替尼联合疗法在碘难治性甲状腺癌中取得卓越疗效:病例报告

Donzé, Charlotte; Leenhardt, Fanny; Vinches, Marie; Eberlé, Marie-Claude; Fersing, Cyril

Thermal Insulation of Protective Clothing Materials in Extreme Cold Conditions

极寒条件下防护服材料的隔热性能

Zemzem, Mohamed; Hallé, Stéphane; Vinches, Ludwig

New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

复发性和/或转移性头颈部鳞状细胞癌免疫治疗后疗效评估面临的新挑战

Alberti, Andrea; Lorini, Luigi; Ravanelli, Marco; Perri, Francesco; Vinches, Marie; Rondi, Paolo; Romani, Chiara; Bossi, Paolo

Confounding factors in the assessment of oral mucositis in head and neck cancer

头颈癌口腔黏膜炎评估中的混杂因素

Lorini, Luigi; Perri, Francesco; Vecchio, Stefania; Belgioia, Liliana; Vinches, Marie; Brana, Irene; Elad, Sharon; Bossi, Paolo

First results of the EORTC-SPECTA/Arcagen study exploring the genomics of rare cancers in collaboration with the European reference network EURACAN

EORTC-SPECTA/Arcagen 研究与欧洲参考网络 EURACAN 合作,探索罕见癌症的基因组学,并公布了初步结果。

Morfouace, Marie; Stevovic, Aleksandra; Vinches, Marie; Golfinopoulos, Vassilis; Jin, Dexter X; Holmes, Oliver; Erlich, Rachel; Fayette, Jerome; Croce, Sabrina; Ray-Coquard, Isabelle; Girard, Nicolas; Blay, Jean-Yves

The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials

头颈部鳞状细胞癌临床试验中治疗和结果的统计学评价

Fortpied, Catherine; Vinches, Marie

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

单克隆抗体在首次人体试验后的临床开发策略:已测试剂量及剂量选择原理

Viala, Marie; Vinches, Marie; Alexandre, Marie; Mollevi, Caroline; Durigova, Anna; Hayaoui, Nadia; Homicsko, Krisztian; Cuenant, Alice; Gongora, Céline; Gianni, Luca; Tosi, Diego